Skip to main content
Caplight Logo









PhageNova Bio, Inc.

PhageNova Bio, Inc.

Private
Summit, New JerseyHealthcare & Life Scienceshttps://phagenovabio.com/

Company Overview

PhageNova Bio, Inc. is a biotechnology company that develops a gene-therapy-based platform combining bacteriophage targeting with adeno-associated virus gene expression for cancer and vaccine applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

gene deliveryAAVPadeno-associated virusbacteriophagetargeted therapygene therapyoncologyvaccine platformvector platformsolid tumorsbiotechdrug discoveryprecision medicinephage therapyviral vector

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PhageNova Bio, Inc. Comparables

Compare PhageNova Bio, Inc. with similar companies based on industry and business-model similarity.

PhageNova Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Siren Biotechnology
82%
LyseNTech
72%
Coastar Therapeutics
72%

PhageNova Bio, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

PhageNova Bio, Inc. Filings

Explore SEC and related filing metadata, where available.

PhageNova Bio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PhageNova Bio, Inc.'s valuation, stock price, and market status.

Is PhageNova Bio, Inc. a public or private company?

PhageNova Bio, Inc. is a private company.

What is the current stock price of PhageNova Bio, Inc.?

PhageNova Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is PhageNova Bio, Inc. worth (valuation)?

Valuation information for PhageNova Bio, Inc. is not publicly available.

Can I buy PhageNova Bio, Inc. stock?

PhageNova Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PhageNova Bio, Inc.'s last funding round?

Funding round information for PhageNova Bio, Inc. is not publicly available.

Who are the main investors in PhageNova Bio, Inc.?

Investor information for PhageNova Bio, Inc. is not publicly disclosed.

Will PhageNova Bio, Inc. IPO soon?

No public IPO plans have been announced for PhageNova Bio, Inc..

How can I track PhageNova Bio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PhageNova Bio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSummit, New Jersey
Employee Range1
Year Founded2012
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?